Wade Walke | SVP, IR |
Brett Monia | CEO |
Beth Hougen | CFO |
Eugene Schneider | Chief Clinical Development Officer |
Onaiza Cadoret | Chief Global Product Strategy & Operations Officer |
Eric Swayze | EVP, Research |
Yanan Zhu | Wells Fargo Securities |
Gary Nachman | BMO Capital Markets |
Do Kim | Piper Sandler |
Gena Wang | Barclays |
Yale Jen | Laidlaw & Co. |
Paul Matteis | Stifel |
Jessica Fye | JP Morgan |
Joseph Stringer | Needham & Company |
Luca Issi | RBC |
Mike Ulz | Morgan Stanley |
Myles Minter | William Blair |
Yaron Werber | Cowen |
Good morning, and welcome to Ionis Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. [Operator Instructions].
As a reminder, this call is being recorded.
At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Please begin, sir.